General Announcement::Unaudited Financial Results for the First Quarter ended 30th June, 2020

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
15-Aug-2020 01:09:11
Status
New
Announcement Sub Title
Unaudited Financial Results for the First Quarter ended 30th June, 2020
Announcement Reference
SG200815OTHRPSAC
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
14/08/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
Unaudited Financial Results (Standalone and Consolidated) for the First Quarter ended 30th June, 2020

Attachments

SGX_RESULT_FINAL.pdf
Total size =1315K